BioCentury | Apr 15, 2013
Company News

Innogenetics NV, Murex sales and marketing update

...$120-$200, and will be sold to clinics and labs able to provide amplified sample DNA. Innogenetics...
BioCentury | Apr 15, 2013
Clinical News

Innogenetics NV regulatory update

...a test that can detect the type of Mycobacterium present, and an Ag85-based DNA vaccine. Innogenetics...
BioCentury | Apr 15, 2013
Company News

Innogenetics NV sales and marketing update

...kit costs $500. INNX will sell the product directly in Belgium, and through distributors elsewhere. Innogenetics...
BioCentury | Nov 8, 2010
Company News

GenMark Diagnostics, Miraca deal

...GenMark received non-exclusive, U.S. rights to Innogenetics N.V.'s HCV genotyping IP and an option to obtain worldwide...
...test offerings. Financial terms were not disclosed. Fujirebio Inc. , a Miraca Holdings company, acquired Innogenetics...
BioCentury | May 24, 2010
Finance

What knight?

...Eli Lilly and Co. (NYSE:LLY) (C) 7/31/08 $46.44 $60.00 10/6/08 $64.96 $70.00 51% 17% 7% Innogenetics N.V./...
BioCentury | Feb 8, 2010
Politics, Policy & Law

Gene patent debate heats up

...indicating that isolated DNA sequences meet the Section 101 test. Sandercock said he successfully represented Innogenetics N.V....
...Sydney, Australia Biotechnology Industry Organization (BIO), Washington, D.C. El Camino Hospital , Mountain View, Calif. Innogenetics N.V....
BioCentury | Jul 14, 2008
Finance

Ebb & Flow

...factor (TGF) beta 3. For the week, Renovo gained 4p to 38.25p. Ebb & Flow Innogenetics...
...offer to €6.50 per share in cash. Gen-Probe (NASDAQ:GPRO), which bid €6.10 per share for Innogenetics...
BioCentury | Jul 14, 2008
Company News

Gen-Probe, Innogenetics, Solvay deal

...Solvay increased its tender offer to acquire diagnostics company Innogenetics from €5.75 to €6.50 per share...
...the company at €200.7 million ($313.6 million). The new price is a 6.6% premium to Innogenetics’...
...to acquire Innogenetics in response to Solvay’s new offer. In June, Gen-Probe offered to acquire Innogenetics...
BioCentury | Jul 9, 2008
Top Story

Solvay ups Innogenetics bid

...Solvay (Euronext:SOLB) looks to have the winning bid for Innogenetics (Euronext:INNX) after announcing Wednesday that it...
...$313.6 million) for 100% of Innogenetics' outstanding shares. The price is a 74% premium to Innogenetics'...
...will offer to purchase Innogenetics warrants and convertible bonds for an undisclosed amount. On Wednesday, Innogenetics...
BioCentury | Jul 7, 2008
Finance

Restructuring watch

...San Diego from Toronto; expects to cut annual costs by $3M starting in 2009 5/26/08 Innogenetics...
...ND $20.9 0.26 3/31/08 $20.1 Closes GENimmune subsidiary and reintegrates GENimmune’s biologicals production unit into Innogenetics...
Items per page:
1 - 10 of 222
BioCentury | Apr 15, 2013
Company News

Innogenetics NV, Murex sales and marketing update

...$120-$200, and will be sold to clinics and labs able to provide amplified sample DNA. Innogenetics...
BioCentury | Apr 15, 2013
Clinical News

Innogenetics NV regulatory update

...a test that can detect the type of Mycobacterium present, and an Ag85-based DNA vaccine. Innogenetics...
BioCentury | Apr 15, 2013
Company News

Innogenetics NV sales and marketing update

...kit costs $500. INNX will sell the product directly in Belgium, and through distributors elsewhere. Innogenetics...
BioCentury | Nov 8, 2010
Company News

GenMark Diagnostics, Miraca deal

...GenMark received non-exclusive, U.S. rights to Innogenetics N.V.'s HCV genotyping IP and an option to obtain worldwide...
...test offerings. Financial terms were not disclosed. Fujirebio Inc. , a Miraca Holdings company, acquired Innogenetics...
BioCentury | May 24, 2010
Finance

What knight?

...Eli Lilly and Co. (NYSE:LLY) (C) 7/31/08 $46.44 $60.00 10/6/08 $64.96 $70.00 51% 17% 7% Innogenetics N.V./...
BioCentury | Feb 8, 2010
Politics, Policy & Law

Gene patent debate heats up

...indicating that isolated DNA sequences meet the Section 101 test. Sandercock said he successfully represented Innogenetics N.V....
...Sydney, Australia Biotechnology Industry Organization (BIO), Washington, D.C. El Camino Hospital , Mountain View, Calif. Innogenetics N.V....
BioCentury | Jul 14, 2008
Finance

Ebb & Flow

...factor (TGF) beta 3. For the week, Renovo gained 4p to 38.25p. Ebb & Flow Innogenetics...
...offer to €6.50 per share in cash. Gen-Probe (NASDAQ:GPRO), which bid €6.10 per share for Innogenetics...
BioCentury | Jul 14, 2008
Company News

Gen-Probe, Innogenetics, Solvay deal

...Solvay increased its tender offer to acquire diagnostics company Innogenetics from €5.75 to €6.50 per share...
...the company at €200.7 million ($313.6 million). The new price is a 6.6% premium to Innogenetics’...
...to acquire Innogenetics in response to Solvay’s new offer. In June, Gen-Probe offered to acquire Innogenetics...
BioCentury | Jul 9, 2008
Top Story

Solvay ups Innogenetics bid

...Solvay (Euronext:SOLB) looks to have the winning bid for Innogenetics (Euronext:INNX) after announcing Wednesday that it...
...$313.6 million) for 100% of Innogenetics' outstanding shares. The price is a 74% premium to Innogenetics'...
...will offer to purchase Innogenetics warrants and convertible bonds for an undisclosed amount. On Wednesday, Innogenetics...
BioCentury | Jul 7, 2008
Finance

Restructuring watch

...San Diego from Toronto; expects to cut annual costs by $3M starting in 2009 5/26/08 Innogenetics...
...ND $20.9 0.26 3/31/08 $20.1 Closes GENimmune subsidiary and reintegrates GENimmune’s biologicals production unit into Innogenetics...
Items per page:
1 - 10 of 222